Product Code: VMR11213751
The global demand for Pulmonary Function Testing Systems Market is presumed to reach the market size of nearly USD 5.07 Billion by 2032 from USD 2.78 Billion in 2023 with a CAGR of 6.91% under the study period 2024-2032.
Pulmonary function test, also known as Lung function tests, is used to diagnose lung disorders such as asthma, respiratory infections, chronic obstructive pulmonary disease (COPD), and others. Pulmonary function tests (PFTs) are noninvasive tests and determine the lungs' functioning and the ability of a person to breathe and make sure about infection-free. The process consists of a precise examination of the patient's pulmonary health over chest x-rays, physical tests, arterial blood gas analysis, and a study of the patient's habits and health history.
MARKET DYNAMICS
The rising predominance of lung diseases such as COPD, asthma, and others, availability of lung function test devices, and rising demand for lung function tests are significant factors stimulating the growth of the market. Technological advancements in lung testing and the increasing geriatric population are also influencing the market growth. Changing lifestyle and smoking addiction leads to several lung problems such as lung cancer, which further drives the growth of the market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Pulmonary Function Testing Systems. The growth and trends of Pulmonary Function Testing Systems industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the Pulmonary Function Testing Systems market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product Type
By Test Type
- Spirometry
- Lung Volume Test
- Gas Diffusion Test
- Exercise Stress Test
- High Altitude Simulation Testing
- Others
By Application
- Chronic Obstructive Pulmonary Disease
- Asthma
- Chronic Shortness of Breath
- Pulmonary Fibrosis
- Others
By Distribution Channel
- Hospital & Clinics Pharmacies
- Brick & Mortar
- E-Commerce
By End-Use
- Hospitals & Clinics
- Diagnostic Centers
- Homecare Settings
- Others
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Pulmonary Function Testing Systems market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Pulmonary Function Testing Systems market include Koninklijke Philips N.V., Medical Equipment Europe, Medtronic, Minato Holdings Inc, Morgan Scientific Inc., Ndd Medizintechnik AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1. PREFACE
- 1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology
2. EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3. PULMONARY FUNCTION TESTING SYSTEMS - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Test Type
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By Distribution Channel
- 3.7.5 Market Attractiveness Analysis By End-Use
- 3.7.6 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend
5. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET ANALYSIS BY PRODUCT TYPE
- 5.1. Overview By Product Type
- 5.2. Historical and Forecast Data Analysis By Product Type
- 5.3. Handheld Historic and Forecast Sales By Regions
- 5.4. Tabletop Historic and Forecast Sales By Regions
6. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET ANALYSIS BY TEST TYPE
- 6.1. Overview By Test Type
- 6.2. Historical and Forecast Data Analysis By Test Type
- 6.3. Spirometry Historic and Forecast Sales By Regions
- 6.4. Lung Volume Test Historic and Forecast Sales By Regions
- 6.5. Gas Diffusion Test Historic and Forecast Sales By Regions
- 6.6. Exercise Stress Test Historic and Forecast Sales By Regions
- 6.7. High Altitude Simulation Testing Historic and Forecast Sales By Regions
- 6.8. Others Historic and Forecast Sales By Regions
7. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET ANALYSIS BY APPLICATION
- 7.1. Overview By Application
- 7.2. Historical and Forecast Data Analysis By Application
- 7.3. Chronic Obstructive Pulmonary Disease Historic and Forecast Sales By Regions
- 7.4. Asthma Historic and Forecast Sales By Regions
- 7.5. Chronic Shortness of Breath Historic and Forecast Sales By Regions
- 7.6. Pulmonary Fibrosis Historic and Forecast Sales By Regions
- 7.7. Others Historic and Forecast Sales By Regions
8. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET ANALYSIS BY DISTRIBUTION CHANNEL
- 8.1. Overview By Distribution Channel
- 8.2. Historical and Forecast Data Analysis By Distribution Channel
- 8.3. Hospital & Clinics Pharmacies Historic and Forecast Sales By Regions
- 8.4. Brick & Mortar Historic and Forecast Sales By Regions
- 8.5. E-Commerce Historic and Forecast Sales By Regions
9. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET ANALYSIS BY END-USE
- 9.1. Overview By End-Use
- 9.2. Historical and Forecast Data Analysis By End-Use
- 9.3. Hospitals & Clinics Historic and Forecast Sales By Regions
- 9.4. Diagnostic Centers Historic and Forecast Sales By Regions
- 9.5. Homecare Settings Historic and Forecast Sales By Regions
- 9.6. Others Historic and Forecast Sales By Regions
10. GLOBAL PULMONARY FUNCTION TESTING SYSTEMS MARKET ANALYSIS BY GEOGRAPHY
- 10.1. Regional Outlook
- 10.2. Introduction
- 10.3. North America Sales Analysis
- 10.3.1 Overview, Historic and Forecast Data Sales Analysis
- 10.3.2 North America By Segment Sales Analysis
- 10.3.3 North America By Country Sales Analysis
- 10.3.4 United States Sales Analysis
- 10.3.5 Canada Sales Analysis
- 10.3.6 Mexico Sales Analysis
- 10.4. Europe Sales Analysis
- 10.4.1 Overview, Historic and Forecast Data Sales Analysis
- 10.4.2 Europe By Segment Sales Analysis
- 10.4.3 Europe By Country Sales Analysis
- 10.4.4 United Kingdom Sales Analysis
- 10.4.5 France Sales Analysis
- 10.4.6 Germany Sales Analysis
- 10.4.7 Italy Sales Analysis
- 10.4.8 Russia Sales Analysis
- 10.4.9 Rest Of Europe Sales Analysis
- 10.5. Asia Pacific Sales Analysis
- 10.5.1 Overview, Historic and Forecast Data Sales Analysis
- 10.5.2 Asia Pacific By Segment Sales Analysis
- 10.5.3 Asia Pacific By Country Sales Analysis
- 10.5.4 China Sales Analysis
- 10.5.5 India Sales Analysis
- 10.5.6 Japan Sales Analysis
- 10.5.7 South Korea Sales Analysis
- 10.5.8 Australia Sales Analysis
- 10.5.9 South East Asia Sales Analysis
- 10.5.10 Rest Of Asia Pacific Sales Analysis
- 10.6. Latin America Sales Analysis
- 10.6.1 Overview, Historic and Forecast Data Sales Analysis
- 10.6.2 Latin America By Segment Sales Analysis
- 10.6.3 Latin America By Country Sales Analysis
- 10.6.4 Brazil Sales Analysis
- 10.6.5 Argentina Sales Analysis
- 10.6.6 Peru Sales Analysis
- 10.6.7 Chile Sales Analysis
- 10.6.8 Rest of Latin America Sales Analysis
- 10.7. Middle East & Africa Sales Analysis
- 10.7.1 Overview, Historic and Forecast Data Sales Analysis
- 10.7.2 Middle East & Africa By Segment Sales Analysis
- 10.7.3 Middle East & Africa By Country Sales Analysis
- 10.7.4 Saudi Arabia Sales Analysis
- 10.7.5 UAE Sales Analysis
- 10.7.6 Israel Sales Analysis
- 10.7.7 South Africa Sales Analysis
- 10.7.8 Rest Of Middle East And Africa Sales Analysis
11. COMPETITIVE LANDSCAPE OF THE PULMONARY FUNCTION TESTING SYSTEMS COMPANIES
- 11.1. Pulmonary Function Testing Systems Market Competition
- 11.2. Partnership/Collaboration/Agreement
- 11.3. Merger And Acquisitions
- 11.4. New Product Launch
- 11.5. Other Developments
12. COMPANY PROFILES OF PULMONARY FUNCTION TESTING SYSTEMS INDUSTRY
- 12.1. Top Companies Market Share Analysis
- 12.2. Market Concentration Rate
- 12.3. Koninklijke Philips N.V.
- 12.3.1 Company Overview
- 12.3.2 Company Revenue
- 12.3.3 Products
- 12.3.4 Recent Developments
- 12.4. Medical Equipment Europe
- 12.4.1 Company Overview
- 12.4.2 Company Revenue
- 12.4.3 Products
- 12.4.4 Recent Developments
- 12.5. Medtronic
- 12.5.1 Company Overview
- 12.5.2 Company Revenue
- 12.5.3 Products
- 12.5.4 Recent Developments
- 12.6. Minato Holdings Inc
- 12.6.1 Company Overview
- 12.6.2 Company Revenue
- 12.6.3 Products
- 12.6.4 Recent Developments
- 12.7. Morgan Scientific Inc.
- 12.7.1 Company Overview
- 12.7.2 Company Revenue
- 12.7.3 Products
- 12.7.4 Recent Developments
- 12.8. Ndd Medizintechnik AG
- 12.8.1 Company Overview
- 12.8.2 Company Revenue
- 12.8.3 Products
- 12.8.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies